PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer

Tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer
2023-07-10
(Press-News.org) JULY 10, 2023, NEW YORK – A Ludwig Cancer Research study has discovered that the presence of relatively high numbers of immune cells known as monocytes in tumors is linked to better outcomes in esophageal cancer patients treated with a combination of chemotherapy and immunotherapy, or immunochemotherapy. Esophageal cancer is the sixth leading cause of cancer mortality worldwide, and the incidence of esophageal adenocarcinoma has been climbing at a relatively swift clip over the past 40 years. Survival times for inoperable or metastatic forms of the cancer range from 6 to 12 months.

Led by Ludwig Oxford Director Xin Lu and former graduate student Thomas Carroll and published in the current issue of the journal Cancer Cell, the study also shows that the degree to which a tumor’s malignant cells are mutated is similarly predictive of survival outcomes. Further, combining measurement of tumor mutational burden (TMB) and tumor monocyte content (TMC) better predicts treatment response than either measurement alone. This suggests that the combined measurement is a potential biomarker for the selection of patients likely to benefit from immunochemotherapy.

“Some cancer patients respond to treatment while some do not, and still others respond only partially,” said Lu. “The challenge is to understand why certain people fall into each category and identify the molecular bases of their heterogeneous responses.”

A clinical trial (LUD2015-005) launched in 2015 by Ludwig Oxford offered a unique opportunity to address this challenge. The 35 patients with inoperable esophageal adenocarcinoma enrolled in this trial, unlike those in many others, received four weeks of immunotherapy with immune checkpoint inhibitors (ICI) alone (either anti-PD-L1, or anti-PD-L1 and anti-CTLA-4) before undergoing 18 weeks of combination immunochemotherapy.

Both healthy and cancerous biopsies were collected from the patients at multiple time points and from multiple sites over the course of their treatment. The researchers then performed single cell RNA sequencing (scRNA-seq) on 65,000 cells from a subset of the clinical trial patients to generate a detailed cellular atlas of the upper gastrointestinal tract, which served as a reference map of all the cell types that can be found in esophageal cancers.

Due to technical and other challenges associated with scRNA-seq—which analyzes the RNA output of individual cells—such analysis was only performed on 8 of the 35 EAC patients in the clinical trial. However, the biopsies of all patients underwent bulk RNA sequencing, a much more cost-effective alternative.

The team then used computational methods—deconvolution algorithms—to determine with high confidence the proportion of different cell types in each biopsy. Deconvolution is a computational tool that combines the biological insights from scRNA and bulk RNA sequencing while compensating for the particular weaknesses of each method—high cost and low resolution, respectively.

"In clinical research, we have to find ways to get as much information as possible from each precious sample. In this case, we wanted to use single-cell sequencing on a subset of those samples to gain detailed insight into the cell composition of these tumors, and combine that knowledge with the statistical power of conducting bulk RNA sequencing on everyone. That's what deconvolution attempts to do,” explained Carroll.

Deconvolution revealed that the number of monocytes in the tumor before treatment was the most reliable predictor of outcome. This finding was surprising because ICI primarily targets the immune system’s T cells, which lead the assault on tumors. “We found that pre-treatment T cell markers are not at all useful in predicting long-term patient outcomes for the treatment used in this trial,” Carroll said.

The researchers hypothesize that the patients with high TMC can generate more pro-inflammatory immune cells from the monocytes in response to ICI therapy than patients with low TMC. Supporting this, they found that after four weeks of ICI, TMC-high patients showed a higher level of dendritic cells and M1 macrophages, which elicit pro-inflammatory or "tumor-killing" responses, while TMC-low patients had more anti-inflammatory or "tumor-supporting" M2 macrophages.

“We don't have the formal demonstration of this yet, and that's where the future research will be,” Lu said.

Using publicly available data, the team also confirmed that the link between high TMC and improved outcomes held for the most common forms of gastric cancer as well.

Aside from identifying the combination of TMB and TMC as potential biomarkers for response to immunochemotherapy, the researchers report that expression of PD-L1—a protein targeted by ICI in the clinical trial—is not a good predictor of patient outcomes for such therapies. They also identify a novel T cell inflammation signature (INCITE) that correlates with ICI-induced tumor shrinkage. This signature could serve as a general indicator of a patient’s responsiveness to immunotherapy, irrespective of their cancer.

This study was supported by Ludwig Cancer Research, Cancer Research UK, the Oxford Experimental Cancer Medicine Centre, AstraZeneca UK Ltd (drug supply) and the National Institute for Health and Care Research Oxford Biomedical Research Centre.

Aside from her Ludwig post, Xin Lu is a professor of cancer biology at the University of Oxford and director of the Oxford Centre for Early Cancer Detection (OxCODE).

 

# # #

 

About Ludwig Cancer Research

Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer research and landmark discovery for more than 50 years. Ludwig combines basic science with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested nearly $3 billion in life-changing science through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers. To learn more, visit www.ludwigcancerresearch.org.

For further information please contact communications@ludwigcancerresearch.org.

 

About the University of Oxford

Oxford University has been placed number 1 in the Times Higher Education World University Rankings for the seventh year running, and number 2 in the QS World Rankings 2022. At the heart of this success are the twin pillars of our ground-breaking research and innovation and our distinctive educational offer.

Oxford is world-famous for research and teaching excellence and home to some of the most talented people from across the globe. Our work helps the lives of millions, solving real-world problems through a huge network of partnerships and collaborations. The breadth and interdisciplinary nature of our research alongside our personalized approach to teaching sparks imaginative and inventive insights and solutions.

Through its research commercialization arm, Oxford University Innovation, Oxford is the highest university patent filer in the UK and is ranked first in the UK for university spinouts, having created more than 200 new companies since 1988. Over a third of these companies have been created in the past three years. The University is a catalyst for prosperity in Oxfordshire and the United Kingdom, contributing £15.7 billion to the UK economy in 2018/19, and supports more than 28,000 full-time jobs.

END


[Attachments] See images for this press release:
Tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer Tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer 2 Tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer 3

ELSE PRESS RELEASES FROM THIS DATE:

Game-playing automaton acts like an ‘irrational’ human

2023-07-10
ITHACA, N.Y. -- Humans make lots of irrational decisions in predictable ways, but what if we’re all just doing our best within the limits of our abilities? Researchers were able to simulate human behaviors using a probabilistic finite automaton, a well-known model of limited computational power. They programmed the automatons to compete against each other in a wildlife poaching game, as either a rhino poacher or a ranger trying to stop the poaching. When the automatons could remember everything, they settled into an optimal game strategy. But when researchers limited their memories, they took some decision-making shortcuts – the same ...

Nearly two thirds of youth would stop vaping without added sweet flavors, menthol, synthetic cooling agents

2023-07-10
COLUMBUS, Ohio – Major progress could be made in fighting the youth vaping epidemic with a complete restriction on sweet flavorings and cooling agents in both cartridge and disposable e-cigarette devices, according to a new study from the Center for Tobacco Research at The Ohio State University Comprehensive Cancer Center. The current U.S. Food and Drug Administration (FDA) flavor ban only applies to cartridge electronic cigarette devices. A new study published in the Journal of Studies on Addiction and Drugs by researchers ...

Girls Deliver: building an integrated, feminist ecosystem to support adolescent girls at the Women Deliver 2023 Conference

2023-07-10
July 10, 2023 — The Population Council’s GIRL Center, and co-hosts AFIDEP, AMPLIFY Girls, Baobab Research Programme Consortium, Children’s Investment Fund Foundation, Coalition for Adolescent Girls, Exemplars in Global Health, FP2030, Girl Effect, Girls First Fund, Conrad N. Hilton Foundation, the National Democratic Institute (NDI), Plan International, PMNCH, Purposeful, Together for Girls, UNICEF, Women Deliver, and The World Bank Africa Gender Innovation Lab, are proud to host the “Girls Deliver: Pre-Conference on Adolescent Girls,” on July 16. This one-day global convening ...

Light-activated molecular machines get cells ‘talking’

Light-activated molecular machines get cells ‘talking’
2023-07-10
HOUSTON – (July 10, 2023) – One of the main ways cells “talk” to each other to coordinate essential biological activities such as muscle contraction, hormone release, neuronal firing, digestion and immune activation is through calcium signaling. Rice University scientists have used light-activated molecular machines to trigger intercellular calcium wave signals, revealing a powerful new strategy for controlling cellular activity, according to a new study published in Nature Nanotechnology. This technology could lead to improved treatments ...

Biomarkers may hold key to precision mental health diagnosis, care

Biomarkers may hold key to precision mental health diagnosis, care
2023-07-10
The study of biomarkers in the brain—powered by cutting-edge machine learning techniques—could redefine the way mental health conditions are categorized and diagnosed and lead to more effective, personalized treatments.  That’s the goal of Yu Zhang, an assistant professor of bioengineering and electrical and computer engineering in Lehigh University’s P.C. Rossin College of Engineering and Applied Science who recently landed major support from the National ...

Navigating the future of underwater geolocalization: how polarization patterns enable new technology

Navigating the future of underwater geolocalization: how polarization patterns enable new technology
2023-07-10
University of Illinois Urbana-Champaign researchers have developed a novel method for underwater geolocalization using deep neural networks that have been trained on 10 million polarization-sensitive images collected from locations around the world. This new study, led by electrical and computer engineering professor Viktor Gruev, along with computer science professor David Forsyth, enables underwater geolocalization using only optical data while providing a tool for tethered-free underwater navigation. These findings were recently published in the journal eLight. “We are showing for the first time, you can geolocate yourself, or a camera, in a number of different ...

Anastasopoulos receives funding for EAGER: building language technologies by machine reading grammars 

2023-07-10
Antonios Anastasopoulos, Assistant Professor Computer Science, received $99,294 from the National Science Foundation for: "EAGER: Building Language Technologies by Machine Reading Grammars." This funding began in June 2023 and will end in late May 2024.  Anastasopoulos said, "This project aims to explore the feasibility of building language technologies while bypassing the need for exorbitant amounts of data, instead turning to already-codified linguistic knowledge. This is of particular importance for bridging the language technology gap for underserved communities: ...

Ungvari & Nichols securing core support for International Global Change Research

2023-07-10
Judit Ungvari, Research and Innovation Officer, Institute for a Sustainable Earth, and Leah Nichols, Executive Director, Institute for a Sustainable Earth, Research and Innovation Initiatives, received $277,602 from the National Science Foundation for: "Collaborative Research: Core Support for Future Earth International Global Change Research."  The grant will provide salary to support Ungvari’s work, travel funds, and support costs for participants to attend annual Sustainability Research and Innovation congresses where the Future Earth assembly occurs.  This funding began in May 2023 and will end ...

Conservation in Indonesia is at risk, a team of researchers who study the region argues

2023-07-10
Indonesia, home to the largest tropical rainforest in Southeast Asia and over 17,500 islands, is a country packed with biodiversity and endangered species. However, scientists studying the region’s species and ecosystems are getting banned from Indonesia, and conservation plans are being blocked. In a letter publishing in the journal Current Biology on July 10, a team of conservation researchers with long-term experience in Indonesia discuss scientific suppression and other research challenges they have witnessed while working in the region. They offer suggestions for how to promote nature conservation, protect data ...

Breathing poison: Microbial life on nitric oxide respiration

Breathing poison: Microbial life on nitric oxide respiration
2023-07-10
Nitric oxide (NO) is a fascinating and versatile molecule, important for all living things as well as the environment. It is highly reactive and toxic, organisms use it as a signaling molecule, it depletes the ozone layer in our planet’s atmosphere, and it is the precursor of the greenhouse gas nitrous oxide (N2O). Moreover, NO might have played a fundamental role in the emergence and evolution of life on Earth, as it was available as a high-energy oxidant long before there was oxygen. Thus, despite its toxicity, it makes perfect sense that microbes use NO to grow. However, research on the topic is scarce and, to date, microbes growing on it have not been cultivated. ...

LAST 30 PRESS RELEASES:

Einstein Probe releases its Science White Paper

Music-based therapy may improve depressive symptoms in people with dementia

No evidence that substituting NHS doctors with physician associates is necessarily safe

At-home brain speed tests bridge cognitive data gaps

CRF appoints Josep Rodés-Cabau, M.D., Ph.D., as editor-in-chief of structural heart: the journal of the heart team

Violent crime is indeed a root cause of migration, according to new study

Customized smartphone app shows promise in preventing further cognitive decline among older adults diagnosed with mild impairment

Impact of COVID-19 on education not going away, UM study finds

School of Public Health researchers receive National Academies grant to assess environmental conditions in two Houston neighborhoods

Three Speculum articles recognized with prizes

ACM A.M. Turing Award honors two researchers who led the development of cornerstone AI technology

Incarcerated people are disproportionately impacted by climate change, CU doctors say

ESA 2025 Graduate Student Policy Award Cohort Named

Insomnia, lack of sleep linked to high blood pressure in teens

Heart & stroke risks vary among Asian American, Native Hawaiian & Pacific Islander adults

Levels of select vitamins & minerals in pregnancy may be linked to lower midlife BP risk

Large study of dietary habits suggests more plant oils, less butter could lead to better health

Butter and plant-based oils intake and mortality

20% of butterflies in the U.S. have disappeared since 2000

Bacterial ‘jumping genes’ can target and control chromosome ends

Scientists identify genes that make humans and Labradors more likely to become obese

Early-life gut microbes may protect against diabetes, research in mice suggests

Study raises the possibility of a country without butterflies

Study reveals obesity gene in dogs that is relevant to human obesity studies

A rapid decline in US butterfly populations

Indigenous farming practices have shaped manioc’s genetic diversity for millennia

Controlling electrons in molecules at ultrafast timescales

Tropical forests in the Americas are struggling to keep pace with climate change

Brain mapping unlocks key Alzheimer’s insights

Clinical trial tests novel stem-cell treatment for Parkinson’s disease

[Press-News.org] Tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer